Introduction
Multiple myeloma (MM) is a clonal B-cell neoplasm resulting in the accumulation of a malignant clone of plasma cells in the bone marrow and accounts for about 10% of all haematological malignancies (Hallek et al., 1998) . Sensitive FISH-based assays have shown that, in common with many other B-cell neoplasms, translocations involving the immunoglobulin heavy-chain (IgH) locus at 14q32 can occur in up to 57-74% of cases (Nishida et al., 1997; Avet-Loiseau et al., 1998; Ho et al., 2001) . The heavy-chain locus is strongly transcriptionally active in plasma cells, and transfer of an oncogene to 14q32 results in its dysregulation. In contrast to most B-cell tumours where 14q32 translocations generally involve the VDJ region, in MM the breakpoints are located within, or in close proximity to switch (S) regions of the IgH locus constant region. These S regions are repetitive noncoding sequences normally associated with the recombination events that lead to alteration of isotype, or class, of the immunoglobulin expressed by a B cell. These recombination events are termed class switch recombination (CSR).
Recurrent chromosome translocations between the IgH locus and various partner loci have been identified in both MM cell lines and patients. The best characterized of these recurrent rearrangements include t(4;14)(p16;q32), t(6;14)(p21;q32), t(6;14)(p25;q32), t(8;14)(q24;q32) t(11;14)(q13;q32) and t(14;16) (q32;q23) (Chesi et al., 1996 (Chesi et al., , 1998 Iida et al., 1997; Richelda et al., 1997; Avet-Loiseau et al., 2001; Shaughnessy et al., 2001) . In addition, a promiscuous array of other chromosomal partners have been identified. These are recurrent events that are also present in cases of monoclonal gammopathy of uncertain significance (MGUS) known to be precursors to clinical myeloma. Proto-oncogene deregulations, a consequence of these rearrangements, are critical early events in the natural history of these disorders. A fuller understanding of the mechanism underlying these events is important in understanding the pathogenic events important in the aetiology of myeloma. Characterization of cell line models, has to some extent, approached this issue and it has been suggested that there are two distinct types of mechanism occurring. The first, thought to be an early event, involves abberrant CSR. The second, thought to be a late event and often a characteristic of cell lines, involves regions of DNA located close to IgH S regions but does not involve CSR ). Similar observations have not been made on primary human material. More recently, the molecular events underlying normal CSR are much better understood following a series of experiments undertaken on mice, suggesting the importance of mismatch repair proteins (Ehrenstein and Neuberger, 1999; Ehrenstein et al., 2001) , AID and NHEJ proteins such as Ku70 (Manis et al., 1998) , Ku80 (Casellas et al., 1998) and DNA-dependent kinase (Rolink et al., 1996) . The relevance of these findings to human CSR and how the process is deregulated in MM is currently an important issue. Information to illuminate these questions can be obtained by studying the molecular characteristics of the translocation breakpoints.
Studying primary patient MM offers a unique situation where it is possible to investigate not only the site and nature of the aberrant CSR events, but also to compare these with recombination events occurring during normal CSR. Studying these events with Southern blotting is difficult because of the lack of sensitivity of the technique. We have devised strategies using polymerase chain reaction (PCR), which allow the identification and isolation of breakpoints occurring within and just outside the S regions located upstream of the m, g and a constant regions of the IgH locus using long-distance vectorette (LDV) PCR (Proffitt et al., 1999) and long-distance PCR. In this present study, we report the characteristics of the genomic breakpoints of a number of t(4;14) chromosomal translocations and the resultant rearrangements.
Results
LDV PCR amplification of 2 t(4;14) translocation breakpoints at IgH S regions in MM patients M23 Both der(4) and der(14) translocation-specific bands were isolated using LDV PCR (Figure 1 ). Sequence analysis (Figure 2a) showed that for the der(14) chromosome, the breakpoint on chromosome 4p16 occurs between exons 4 and 5 of the MMSET gene and Sa (Figure 3a) . The der (4) were subjected to LDV PCR amplification using primer pairs g1 : g2, (lanes 1-4) and 5m1 : 5m2 (lanes 5-6). Aliquots of each reaction were analysed on a 0.9% agarose gel with 500 bp ladder as a marker (far right lane). Amplification of HindIII and EcoRI libraries with primer pair a1 : a2 produced bone-marrow-specific, nongermline fragments of 2.2 and 1.2 kb, respectively, with LDV PCR. The vectorette end of the EcoRI fragment matched sequence from an EcoRI site on cosmid L184d6. Sequence from the other end was found to match sequence from the 3 0 side of Sa switch region where the initiating primers a1 : a2 were located. LDV PCR also generated a bone-marrow-specific, nongermline 3.5 kb product, when primers 5m1 and 5m2 were used with a PvuII library 0 flanking human switch m sequence (Genbank X97051) and nucleotides 27-70 are homologous to bases 1186-1143 of 4p16 sequence on cosmid L184d6 (Genbank Z49236). In the (lower) der (14) sequence nucleotides 1-33 are homologous to bases 1213-1178 of 4p16 sequence on cosmid L184d6 (Genbank Z49236), and nucleotides 33-69 are homologous to bases 2106-2142 of human a switch sequence (Genbank L19121). Sequence common to both derivative chromosomes (aagctgtct) is underlined. A region of microhomology at the der 14 breakpoint (ct) is marked in bold type. (b) Patient M62. The sequence of the breakpoint junction and alignment with germline MMSET sequence and germline human switch m sequence. Nucleotides 1-33 are homologous to bases 1027-1059 of human switch m sequence (Genbank X56795), and nucleotides 34-84 are homologous to bases 488-540 of cosmid L75B9d (Genbank Z69377). (c) Patient M85. The sequence of the breakpoint junctions and alignments with germline 4p16 sequence and germline Sg3 sequences. In the (upper) der (4) sequence nucleotides 1-28 are homologous to bases 1257-1284 of human g3 switch sequence (Genbank U39935), and nucleotides 30-73 are homologous to bases 14 545-14 503 of 4p16 sequence on cosmid L184d6 (Genbank Z49236). In the (lower) der (14) sequence nucleotides 1-26 are homologous to bases 14 576-14 551 of 4p16 sequence on cosmid L184d6 (Genbank Z49236), and nucleotides 30-74 are homologous to bases 1300-1346 of human g3 switch sequence (U39935). (d) Patient M71. The sequence of the breakpoint junctions and alignments with germline MMSET sequence and germline Sm and Sg sequences. In the (upper) der (4) sequence nucleotides 1-29 are homologous to bases 2790-2818 of human switch m sequence (Genbank X56795), and nucleotides 30-63 are homologous to bases 117-183 of 4p16 sequence on cosmid L75B9C (Genbank Z69653). In the (lower) der(14) sequence nucleotides 1-25 are homologous to bases 148-124 of 4p16 sequence on cosmid L75B9C (Genbank Z69653), and nucleotides 25-66 are homologous to bases 2271-2336 of human g2 switch sequence (Genbank U39934). A region of microhomology at the der (14) (14) breakpoint sequences shows that there was replication of 9 bp of 4p16 sequence (AAGCTGTCT), which was present in both junctions ( Figure 2a ). There was also a 2 bp region of microhomology (ct) on the der(14) join and two apparent mutations in the Sa part of this sequence, no apparent mutations were observed on der(4). M62 LDV PCR generated six nongermline, bonemarrow-DNA-specific fragments when primers 5m1 and 5m2 were used to amplify vectorette libraries from patient M62, namely RsaI (1.2 kb), PvuII (1.4 kb), BamHI (1.5 kb), BglII (2.5 kb), HincII (3.5 kb) and EcoRI (4.5 kb); both the BamHI and BglII fragments were cloned and sequenced. Sequence generated from the BglII fragment from the vectorette end was shown to initiate from a BglII site located on cosmid L75B9C (Genbank Z69653) at nucleotide 5499. This sequence also contains an EcoRI site at nucleotide 3625, and a HincII site at nucleotide 4385 whose positions correspond to the other bands obtained with LDV PCR. The breakpoint on 4p16 was found to be located on the neighbouring clone (L75B9D) at nucleotide 540, beyond the BamHI, PvuII and RsaI restriction sites amplified by LDV PCR (Figure 3b ). This breakpoint is 5 0 of the MMSET gene exon 1a and is located within the intron between exons 2 and 3 of another gene, LETM1 (Endele et al., 1999) . The other side of the fragment was confirmed to be 5 0 Sm sequence with the breakpoint located within the Sm switch region pentameric repeats. There were no mutations or microhomology at the breakpoint (Figure 2b ). LDV PCR was not able to isolate a der(14) chromosome breakpoint using the 3 0 primer sets.
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Screening for t(4;14) by long-distance PCR
This method was used to screen the 55 cases of MM, including cases M23 and M62, which had previously been shown to be positive for the t(4;14) event using LDV PCR. DNA isolated from the bone marrow of five cases (approximately 9%) generated fragments ranging in size from approximately 1.9-11.4 kb, indicating the presence of a t(4;14) translocation (Figure 4a ). The positive samples were M23, M65, M71, M85 and M90 (Figure 4b ). The remaining samples, including M62, were PCR negative, although amplification of a 17.5 kb product from the unrelated b-globin gene cluster using specific primers from the LA PCR Genome DNA set (TaKaRa) demonstrated all samples to be suitable for long PCR (data not shown).
M23 Both the der(4) and der(14) breakpoints were characterized using LDV PCR. The breakpoints of the long PCR products (Figure 3b ) were sequenced and found to match those seen previously (Figure 2a ).
M85
The der(4) and der(14) breakpoints obtained by the long PCR screening method were mapped by restriction analysis between an EcoRI site and an XbaI site within cosmid L184d6. Sequence analysis of both of the recombination sites demonstrated that the breakpoint in 4p16 occurs between exons 2a and 3 of the MMSET gene. On chromosome 14, the breakpoints were seen to occur in Sg3 and on both derivative chromosomes (Figure 4a ). For der(4), it was clearly shown that Sm sequence was first joined to Sg3 sequence before a recombination site with 4p16 was observed (Figure 2c) . It was noted that as a result of the recombination event four bases (tcct) were lost from 4p16 in the formation of the two reciprocal chromosomes.
M71 A der(14) breakpoint was isolated within in a 4.7 kb fragment using primers from 14q32 and 4p16, and was mapped by restriction analysis between a SmaI and a HindIII site on cosmid L75b9C. Sequencing showed that the breakpoint in 4p16 occurs upstream from the exon 1a of the MMSET gene (Figure 2d ). The breakpoint on der(14) in chromsome14 occurs in Sg2. There was 1 bp of microhomology (c) between the two sequences at the joining point. Although the screening assay did not produce a der(4) product we were able to isolate this breakpoint using specially designed primers close to the 4p16 breakpoint together with one 5 0 Sm primer, 5m1. This product was cloned and sequenced, there was no microhomology between the 4p16 sequence and that of Sm at the der(4) chromosome recombination site (Figure 2d ). It was noted that six bases (gcgcag) were lost from 4p16 in the formation of the two reciprocal chromosomes.
RNA was extracted from the bone marrow of M71. An RT-PCR assay monitoring expression of FGFR3 (Richelda et al., 1997) was positive, showing a correlation between the t(4;14) at the genomic level and ectopic expression of this gene (result not shown). The presence of an IgH-MMSET hybrid transcript associated with t(4;14) was also looked for, using RT-PCR, which demonstrated the expression of a hybrid product formed between Jh6 of the IgH locus and exon 5 of the MMSET gene (Sibley et al., 2002) .
Patient M65
The der(4) breakpoint was shown by restriction analysis mapping and sequence analysis to be located on cosmid L75b9B downstream from exon 1a of the MMSET gene on 4p16. On 14q32, the breakpoint was presumed to occur in the Sm region but sequencing showed apparent recombination between Sm and Sa, since there was a small amount of sequence homologous to an Sa region that was joined to 4p16 sequence, suggesting that a hybrid switch had been formed (Figure 2e ). The reciprocal der(14) translocation product was not isolated.
M90
The breakpoint for der(14) was shown by restriction analysis mapping and sequence analysis to be located at the start of cosmid L75b9C, upstream from exon 1a of the MMSET gene on 4p16 (Figure 2f ). The breakpoint on chromosome 14q32 was located in an Sa switch region, there was no microhomology at the join. The reciprocal der(4) translocation product was not identified.
Patient M57 A 4 kb band, specific to marrow DNA, was obtained using Jh6 and MM5R primers, the expected smaller band could not be achieved using Im and MM5R primers, suggesting that the Im sequence was deleted or mutated. However, the appropriate band could be obtained with material from patient M23, which has a breakpoint in the same region of 4p16, in a PCR using the same primers, undertaken in parallel. Internal primers were designed so that a 1.7 kb product across the der(4) breakpoint was obtained for M57. The 14q32 IgH sequence recombination site is 5 0 of Sm, with the recombination site on 4p16 occurring between exons 4 and 5 on the MMSET gene at 1388 bp on cosmid L184d6 (Figure 2g ). Unfortunately, not enough genomic DNA material was left to investigate the anomaly with the Im sequence or to determine the presence of a reciprocal der (14) product. Some RNA material was extracted from the bone marrow of M57, and FGFR3 and IgH-MMSET hybrid transcript expression were both found to be present (Sibley et al., 2002) .
One further t(4;14) breakpoint (Man1) was obtained using LDV PCR by amplification of an EcoRI library with 5m primers. The resulting fragment was sequenced and shown to initiate from an EcoRI site on cosmid L75B9 while the other end matched sequence from 5 0 Sm, giving a der(4) breakpoint. The breakpoint sequence was shown to have a 4 bp region of microhomology (gttg) (Figure 2h ).
Position of MM breakpoints on chromosome 4p16 for the 7 patients with t(4;14)
The breakpoints isolated on 4p16 are summarized on a map ( Figure 5 ). The breakpoints appear in two distinct groupings over the MMSET locus spanning the 5 0 control region to 3 0 of exon 4. Figure 4 Long PCR screening for t(4;14) (a) Results from the t(4;14) PCR-based screening assay. Nongermline fragments generated from three representative positive samples. Genomic DNA was isolated from bone marrow (BM) and peripheral blood (PB) of patients M90, M85 and M23. The samples were subjected to long PCR amplification using primer pairs MM1 : 3A, 5M : MM4R and 5M : MM5R, respectively. Aliquots of each reaction were analysed on a 0.8% agarose gel with 500 bp ladder as a marker (far right lane). (b) Table detailing the size and generating primer pair for all nongermline DNA fragments isolated from the five positive (out of 55 cases screened) for the t(4;14) event. No der(4) fragment could be detected for cases M71 and M90 (ND). No der(14) fragment could be detected for M65 (ND). ND, not detected Genomic chromosomal breakpoints of t(4;14) myeloma J Fenton et al
Position of MM breakpoints close to or within Sm on chromosome 14q32
The location of breakpoints associated with CSR and translocation events in MM patients, for the IgH locus at 14q32, are summarized in Figure 6 . All five previously published t(4;14) breakpoints (three cell lines and two tumours) are seen to occur within the pentameric repeat sequences. We have isolated three more Sm breakpoints, as well as two breakpoints in the 5 0 flanking region. This is the first report of IgH breakpoints in the flanking region of the Sm, region in t(4;14) MM.
Discussion
We have characterized eight cases with the t(4;14) where sequence from the MMSET locus on 4p16 has been translocated into the IgH region, confirming that the PCR-based assays are able to detect t(4;14) translocations. The percentage of t(4;14) cases detected compares well with FISH studies (Avet-Loiseau et al., 1998) and our own RT-PCR screening for t(4;14)-specifc MMSET or FGFR3 expression (Sibley et al., 2002) , strongly suggesting that most breaks on 4p16 occur within the approximately 60 kb region screened. We have also confirmed that the IgH constant region is the targeted area on 14q32, although not specifically the switch regions. The less frequently used Se and sm/sd sequences were not screened in our study but it is unlikely that these switch regions are commonly involved in aberrant CSR. Since all the t(4;14) cases express either IgA or IgG, the illegitimate CSR associated with the t(4;14) event must have occurred on the nonproducing IgH allele. In one patient (M23), there is a replication of 4p16 sequence at both the der(14) and der(4) breakpoints. This indicates that the breakpoints on 4p16 are staggered, and that the region between two breaks has been replicated. For the two other reciprocal cases, there were apparent deletions of 4p16 sequence of 4 and 5 bp, respectively. At the time of writing, the detailed structure of reciprocal breakpoints has only been reported for nine translocations, all of these in MM cell lines ), we add three new primary patient samples to this list. A small number of 4p16 breaks may occur outside of the screened region on 4p16. Patient M62 is an example of this and was detected employing LDV PCR. The breakpoint site in this case lies within the LETM1 locus (Endele et al., 1999) , telomeric to MMSET, although this may also be within the 5 0 regulatory region of the MMSET gene. LETM1 is in the opposite transcriptional orientation to MMSET so no hybrid transcripts can be initiated between IgH and LETM1 exons (Endele et al., 1999) . The reason why an approximately 60 kb region of chromosome 4p16 is targeted in the t(4;14) translocation is unclear. The defined breakpoint grouping within the 5 0 region of the MMSET gene on 4p16 is in contrast to both the t(11;14)(q13;q32) and the t(14;16)(q32;q32) translocations in MM where the breakpoints on the partner chromosome have been scattered throughout a 500 and 500-1300 kb region, respectively, (Ronchetti et al., 1999; Bergsagel and Kuehl, 2001) .
All the breakpoints reported in this study are located in, or are proximal to, S regions justifying speculation that the translocations are the result of an error in CSR. However, errors in somatic hypermutation (SHM) has also been proposed as a mechanism that can mediate IgH translocations in MM Kuppers and Dalla-Favera, 2001) , and information from the structure of the breakpoints can help identify as to which is the most likely mechanism. There are striking similarities between SHM and CSR, suggesting that there is a common machinery mediating both of these processes Kinoshita and Honjo, 2001 ). These include the need for target transcription, the involvement of DNA cleavage and the requirement for activation-induced cytidine deaminase (AID), a potential RNA editing enzyme . Recent evidence demonstrates that AID is required for the localization of the Nijmegen breakage syndrome protein (Nbs1) and phosphorylated H2A histone family member X (g-H2AX), which help facilitate DNA double-strand break repair, to the IgH locus during CSR in mice (Petersen et al., 2001) . It has also been proposed that AID initiates CSR by inducing mutations in Sm DNA (Petersen et al., 2001) , these lesions may lead to breaks in the DNA that are repaired by nonhomologous end-joining (NHEJ) proteins, which could lead eventually to CSR involving two S regions. NHEJ proteins such as Ku70, Ku 80 and DNA PKcs, which together make up DNA protein kinase and ligases such as LigIV and XRCC4, have all been implicated in the process Manis et al., 2002) . Micebased studies implicate the presence of AID for the induction of Sm-specific lesions, both immediately 5 0 of and within the Sm core repeats (Petersen et al., 2001) . These are at the very same sites, both flanking and within Sm, where recombination in legitimate CSR occurs (Dunnick et al., 1993; Lee et al., 1998; Kinoshita et al., 1999) . Class switch recombination breakpoints from isotype-switched myeloma also cluster in the region just outside or at the 5 0 end of the Sm region (Zhang et al., 1995; Fenton unpublished results) . We also observed that the illegitimate CSR recombination breakpoints occurring in seven t(4;14) patients, where the appropriate der(4) breakpoints were sequenced, had the same type of distribution. Two patients had breakpoints within the 5 0 flanking region of Sm with the remaining five occurring in the core repeat sequences. This provides good evidence that AID-mediated events are involved in the processes leading to IgH translocations in MM.
Knockout studies of mismatch repair proteins including PMS2 and Msh2 have shown that there are specific differences between SHM and CSR as well as similarities. In mice MSH2 deficiency decreases the number of mutations in SHM, the actual occurrence of CSR promotes certain hot spots in the Sm sequence breakpoints (Ehrenstein and Neuberger, 1999) . PMS2 deficiency only affects CSR, and not SHM, in knockout mice promoting a microhomology-mediated end-joining mechanism between Sm and downstream sequences (Ehrenstein et al., 2001 ). An analysis of the breakpoints, which we have isolated in myeloma in IgH translocation events, shows only one example of microhomology suggesting that PMS2 deficiency does not seem to be involved in illegitimate CSR recombination mechanism resulting in IgH translocations in MM.
The location of IgH translocation breakpoints in MM cell lines and tumours from previous studies has been recently summarized . Only one out of six previously recorded der(4) breakpoints from t(4;14) cases did not have a breakpoint located in Sm. The exception was reportedly located in the Sa1 portion of a hybrid Sm/Sa1 from a cell line. We have observed this phenomenon in two primary t(4;14) cases. In one patient, there was a join between Sm and downstream Sg3 sequence before a recombination with sequence from 4p16. We also observed a der(4) breakpoint region where sequence from 4p16 was joined to a small run of sequence homologous to Sa and then the rest of the sequence was derived, as expected, from Sm. Such observations could conceivably be the result of sequential CSR between Sm sequence, the appropriate downstream S sequence and then a later translocation event involving the IgH locus and the 4p16. Alternatively, there could also have been a complex three-way recombination event. It is our thought that this latter theory is less likely so that the more likely scenario involves a later translocation event. In most cases, a B cell undergoes an IgH translocation event within a germinal centre as a relatively early event. We propose a second scenario that involves a B cell that has legitimately rearranged its IgH locus, that is, has undergone CSR, but the same allele then undergoes the translocation event at a later time point. The translocation mechanism need not necessarily be a sequential CSR event (as described by Mandler et al., 1993) , nor indeed SHM, but would define a distinct molecular subtype of MM, and it is not a reference to the secondary IgH translocations associated with MM progression and (usually) c-myc translocations in MM cell lines . Therefore, the crucial neoplastic event that juxtaposes the IgH enhancers to the critical oncogene(s) associated with immortalization of plasma cells occurs at a later stage in B-cell development. A recent model has been proposed for a multistep model of PC oncogenesis where 14q32 translocations make up one of the earliest transforming events, myelomas are then categorized according to IgH translocation partner and incidence of del(13), but the model does not take into account where the breakpoints occur on the IgH locus (Avet-Loiseau et al., 2002 ). An alternative model (Kuehl and Bergsagel, 2002) does consider that IgH translocations mostly occur within switch and Jh regions but simply denotes these as primary translocations. We propose that there is a subset of these primary cases, where the primary translocations occur after legitimate CSR events; this is independent of the translocation partner and may not necessarily be meditated via an illegitimate CSR, or SHM, mechanism.
Materials and methods
Patient material
Bone marrow aspirates were collected from 55 patients with MM undergoing standard diagnostic procedures. The percentage of malignant plasma cells in the bone marrow was assessed by both morphologic analysis and flow cytometry, and was greater than 10% in all cases described. High molecular weight genomic DNA was prepared from all samples as previously described (Proffitt et al., 1999) . One further MM patient DNA sample was later obtained from Manchester.
Long-Distance Vectorette PCR
We have developed a one-sided (inverse) PCR technique, LDV PCR, that allows the amplification and characterization of recombination events occurring within, or very close to, IgH switch region sequences (Proffitt et al., 1999) . Vectorette libraries were synthesized using high molecular weight DNA from MM patient blood and bone marrow. The technique used 3 0 flanking primers of Sm (m1 and m2), Sg (g1 and g2) and Sa (a1 and a2) to isolate der(14) breakpoints, as described previously (Proffitt et al., 1999) . In addition, a pair of nested primers that bind to sequence 5 0 to Sm was used to identify recombination events on the other derivative chromosome in any reciprocal translocation involving the IgH locus. These primers, designed to bind to 5 0 flanking sequences of Sm (Figure 7a (Figure 7 ). All potentially interesting fragments obtained, that is, anything not amplified with germline (blood or buccal) samples, were amplified once again completely from the original vectorette library in order to prove that they were not artefacts. Initially, 15 of the original MM bone marrow samples were screened using this technique.
Long PCR
Having obtained two t(4;14) breakpoints with LDV PCR (see results) from 15 samples tested, a specific PCR strategy was devised to specifically isolate and characterize the genomic breakpoints in the t(4;14) translocation (Chesi et al., 1997; Richelda et al., 1997) . All the 55 MM patient samples were screened. This translocation occurs in approximately 10-15% of patients with myeloma (Richelda et al., 1997; Sibley et al., 2002) and the breakpoints appear localized to a 60 kb region of chromosome 4p16. Using primers covering this region on 4p16 together with primers flanking the m, g and a switch regions on chromosome 14q32, the aim was to screen this region for t(4;14) translocations. Owing to the orientation of the IgH locus on chromosome 14q32, PCR using a 3 0 S primer ( Figure 7a ) in combination with a primer on 4p16 that extends towards the centromere (MM1-5) (Figure 7b ) will detect the der(14) component of a reciprocal t(4;14). Likewise a 5 0 S : MM1-5R combination (Figure 7b ) will amplify the der(4) component. In view of the potentially large PCR products generated, a long PCR technique using specific Taq DNA polymerase was employed. Primers were grouped into combinations that allowed each sample to be initially screened using only four multiplex reactions. Amplification of samples containing 4p16 sequences fused to m, g1-4 or a1-2 S regions would generate discrete PCR product bands. 0 CTGAGTCCCAGCCTCAA CGCAGA. PCR amplifications were performed using LA Taq polymerase (TaKaRa, Japan). Each 50 ml reaction contained 400 mm each dNTP, 1 Â LA buffer II (Mg 2+ free), 2 mm MgCl 2 , 10 pmol each primer, 200 ng genomic DNA and 2.5 U LA Taq enzyme. After an initial incubation at 951C for 3 min using a HOT start protocol, each reaction was subjected to 35 cycles consisting of 951C for 30 s, 681C for 12 min. After the final cycle, each reaction was incubated at 721C for a further 10 min. Aliquots of each PCR reaction were analysed by 0.9% agarose gel electrophoresis.
Primers were pooled in the following combinations: P1 (MM1-3), P2 (MM3-5), P3 (MM1-3R), P4(MM3-5R), S1(3M, G,A) and S2 (5M,G,A). Multiplex PCRs, P1 : S1, P2 : S2, P3 : S2 and P4 : S2 were used to screen samples. For all positive samples the multiplexes were split to allow the specific pair of primers for amplification to be determined.
Cloning and analysis of PCR products
Gel-purified PCR products were blunt-end cloned into the vector pT7Blue (Novagen) and subjected to automated DNA sequencing using the Big Dye Terminator Cycle Sequencing Kit in an ABI Prism 377, as previously described. (Proffitt et al., 1999) .
RT-PCR
RNA was extracted from the bone marrow of myeloma patients using the RNeasy minikit, (Qiagen, West Sussex, UK) and cDNA prepared using Superscript RT enzyme (Invitrogen Life Technologies, Paisley, UK). The quality of the cDNA was first tested using c-Abl primers. Expressed FGFR3 was amplified using specific primers spanning exons 9-10 of FGFR3 (Richelda et al., 1997) . PCR reactions were undertaken using LA taq polymerase (TaKaRa).
